Mainz Biomed N.V. reported earnings of -$ 0.08 per QUCY share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.08 |
| Earnings Per Share (Surprise) | -$ 0.08 ($ 0.00) |
| Last Year's EPS | -$ 2.65 |
| EPS YoY Change |
Out of the last 9 earnings reporting periods, Mainz Biomed N.V. beat analysts’ expectations 6 times and fell short of expectations 1 time(s). Mainz Biomed N.V. reported earnings per share of -$ 0.08 in the last report falling to reach an estimated EPS of -$ 0.08 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.08 | -$ 0.08 | -$ 10.80 | |
| Sep 9, 2026 | -$ 38.80 | -$ 15.60 | - | |
| Aug 14, 2026 | -$ 0.02 | -$ 0.56 | -$ 18.00 | |
| May 15, 2026 | -$ 38.80 | -$ 0.21 | -$ 36.40 | |
| Sep 26, 2025 | -$ 12.67 | -$ 2.65 | - | - |
| Apr 9, 2024 | -$ 12.67 | -$ 10.80 | - | - |
| Nov 16, 2023 | -$ 18.93 | -$ 15.60 | - | - |
| May 16, 2023 | -$ 19.60 | -$ 18.00 | - | - |
| Sep 7, 2022 | - | -$ 36.40 | - | - |
Mainz Biomed N.V.’s stock was trading at $ 0.6245 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, QUCY’s price increased to $ 0.633 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.08 | $ 0.6245 | $ 0.633 | |
| Sep 9, 2026 | | $ 1.42 | $ 1.37 | |
| Aug 14, 2026 | -$ 0.56 | $ 1.42 | $ 1.47 | |
| May 15, 2026 | -$ 0.21 | $ 3.00 | $ 3.30 |
Mainz Biomed N.V. released its most recent earnings reports in November 2026, September 2026, August 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Mainz Biomed N.V. missed analysts’ expectations during the last earnings period by
